Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07044505 · ClinicalTrials.gov registry record · NA
Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
A NA study of Gynecologic Cancer and Uterine Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07044505: Recruiting NA study of Gynecologic Cancer and Uterine Cancer, sponsored by Stanford University.
NCT07044505 is a NA study of Gynecologic Cancer and Uterine Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07044505, a NA study of Gynecologic Cancer and Uterine Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a designed as a to test the clinical and technical feasibility of using this novel uterine lavage collection catheter to collected UL samples from up to 50 individuals undergoing gynecologic surgery and to describe the cellular composition of these samples. In order to do this, it is a prospective consecutively-enrolled cohort of 50 participants, all of who will receive the intervention of uterine lavage collection.
Primary Outcome
Quantification and classification of cell types obtained from uterine lavage specimens using cytology and/or flow cytometry.
Conditions Studied
Interventions
- PROCEDURE Uterine Lavage
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-19 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07044505 shows while recruiting
NCT07044505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Uterine Lavage is the first listed.
NCT07044505 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07044505 about?
NCT07044505 is a clinical study titled "Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery". This study is a designed as a to test the clinical and technical feasibility of using this novel uterine lavage collection catheter to collected UL samples from up to 50 individuals undergoing gynecologic surgery and to describe the cellular composition of these samples. In order to do this, it is a...
What is the current status of trial NCT07044505?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-19. Estimated completion is 2026-12.
What conditions does trial NCT07044505 study?
This clinical trial studies the following conditions: Gynecologic Cancer, Uterine Cancer, Gynecologic Disease, Gynecological Surgery.
What interventions are being tested in trial NCT07044505?
The interventions under investigation include: Uterine Lavage (PROCEDURE).
Who is sponsoring clinical trial NCT07044505?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07044505 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07044505's enrollment target sits among peer trials
50 32nd of 55 higher than 23 of 55 other Gynecologic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gynecologic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Activity Coaching During Pelvic Radiation Therapy
RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI